February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 17, 2025

Secondhand Smoke and Low Vitamin D Linked to Cognitive Decline

SHS exposure had [a] synergistic effect with VDD on cognitive impairment among [the] elderly, recent study reports showed.

Conexiant

February 17, 2025

Physician Turnover After Private Equity Exits

Researchers found physicians in private equity-exiting practices were less likely to stay and more likely to join larger groups within 2 years.

Conexiant

February 14, 2025

First Rapid-Acting Insulin Biosimilar Gets FDA Approval

FDA approves Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog for glycemic control in adult and pediatric diabetes patients, expanding treatment accessibility.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 12, 2025

GLP-1 Agonists Linked to Fewer COPD Flares

SGLT-2 inhibitors and GLP-1 receptor agonists were associated with a reduced risk of moderate or severe COPD exacerbations compared with DPP-4 inhibitors in adults with type 2 diabetes.

Conexiant

February 11, 2025

Oral Regimens for Rifampin-Resistant TB

"The results of the endTB trial improve prospects for effective, simple, all-oral treatment for adults and children with this disease."

Conexiant

February 11, 2025

Study Links Post-COVID Lesions to Threefold Risk of Failure

SARS-CoV-2 infection is associated with accelerated coronary plaque progression and a nearly threefold higher risk of target lesion failure, according to a new study.

Conexiant

February 11, 2025

Skin Manifestations of COVID: IFN-1 Link Found

Pseudochilblains were linked to exaggerated IFN-1 production by plasmacytoid dendritic cells, according to new findings on COVID-19-related skin diseases.

Conexiant